EICHOR
● Active Not Recruiting
A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer
Condition: Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer · Sponsor: BeiGene
About this study
This is a Phase 1b/2 study to investigate the efficacy and safety of alcestobart (LBL-007) plus tislelizumab when administered in combination with bevacizumab plus fluoropyrimidine, and alcestobart in combination with bevacizumab plus fluoropyrimidine versus bevacizumab plus fluoropyrimidine to participants with colorectal cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (64)
| Alaska Oncology and Hematology, Llc | Anchorage, Alaska, United States | — |
| Banner Md Anderson Cancer Center | Gilbert, Arizona, United States | — |
| Helios Clinical Research | Cerritos, California, United States | — |
| Valkyrie Clinical Trials | Los Angeles, California, United States | — |
| Usc Norris Comprehensive Cancer Center (Nccc) | Los Angeles, California, United States | — |
| UCLA Hematologyoncology | Los Angeles, California, United States | — |
| Hoag Memorial Presbyterian | Newport Beach, California, United States | — |
| Kaiser Permanente Northern California | Vallejo, California, United States | — |
| Baptist Md Anderson Cancer Center | Jacksonville, Florida, United States | — |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne, Indiana, United States | — |
| Baptist Health Lexington | Lexington, Kentucky, United States | — |
| University of Kentucky Markey Cancer Center | Lexington, Kentucky, United States | — |
+ 52 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.